ARCH VENTURE MANAGEMENT, LLC
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | VIR | 12.92M | $77.89M |
 | ERAS | 11.06M | $41.13M |
 | GOSS | 8.06M | $24.97M |
 | BEAM | 4.54M | $125.85M |
 | MAZE | 4.12M | $170.69M |
 | RAPP | 3.73M | $113.13M |
 | LYEL | 2.76M | $84.92M |
 | TXG | 738K | $12.03M |
 | QTTB | 320K | $1.06M |
Vir Biotechnology, Inc.
VIR
Shares Held
12.92M
Value
$77.89M
Erasca, Inc.
ERAS
Shares Held
11.06M
Value
$41.13M
Gossamer Bio, Inc.
GOSS
Shares Held
8.06M
Value
$24.97M
Beam Therapeutics Inc.
BEAM
Shares Held
4.54M
Value
$125.85M
Maze Therapeutics, Inc.
MAZE
Shares Held
4.12M
Value
$170.69M
Rapport Therapeutics, Inc. Common Stock
RAPP
Shares Held
3.73M
Value
$113.13M
Lyell Immunopharma, Inc.
LYEL
Shares Held
2.76M
Value
$84.92M
10x Genomics, Inc.
TXG
Shares Held
738K
Value
$12.03M
Q32 Bio Inc.
QTTB
Shares Held
320K
Value
$1.06M